AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended March 31, 2021. Recent Highlights AgeX entered into a sponsored research agreement with The Ohio State University using AgeX’s brown adipocyte...

Click to view original post